{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:15:51Z","timestamp":1788279351129,"version":"build-2803163510"},"reference-count":19,"publisher":"The Journal of Rheumatology","issue":"Suppl 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2026,4,29]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>Psoriasis is a chronic, immune-mediated disease affecting the skin. Its prevalence varies by region (0.2-9%), and some patients may develop joint involvement. For mild disease, and as adjuncts in moderate disease, topical therapies remain the foundation of care. Classical agents include topical corticosteroids and vitamin D analogs. Other legacy options (tazarotene, salicylic acid, coal tar, and calcineurin inhibitors) serve as adjuvants with variable efficacy. Recent advances have led to new targeted nonsteroidal topicals such as tapinarof (aryl hydrocarbon receptor agonist) and roflumilast (phosphodiesterase 4 inhibitor). We summarize evidence, propose practical prescribing recommendations for nondermatologists, and position new agents within a steroid-sparing, precision framework. A persistent challenge is affordability, in which high acquisition costs for novel topicals may restrict real-world access unless supported by pricing and reimbursement policies. This work was presented at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 annual meeting in Bogot\u00e1 as a concurrent session.<\/jats:p>","DOI":"10.3899\/jrheum.2026-0440","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:20:19Z","timestamp":1780316419000},"page":"12-14","source":"Crossref","is-referenced-by-count":0,"title":["Topicals for Psoriasis: Classical Drugs, New Concepts, and New Medications"],"prefix":"10.3899","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0113-2684","authenticated-orcid":false,"given":"Juan Raul","family":"Castro-Ayarza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1173-8292","authenticated-orcid":false,"given":"Manuel Dario","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"2026090108200770000_53.Suppl_2.12.1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339"},{"key":"2026090108200770000_53.Suppl_2.12.2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ad.2020.09.015","article-title":"Prevalence of psoriasis in Colombia according to the National Health Registry","volume":"113","author":"Fern\u00e1ndez-\u00c1vila","year":"2022","journal-title":"Actas Dermo-Sifiliogr"},{"key":"2026090108200770000_53.Suppl_2.12.3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000512930","article-title":"Topical treatment of psoriasis vulgaris: the Swiss treatment pathway","volume":"237","author":"Maul","year":"2021","journal-title":"Dermatology"},{"key":"2026090108200770000_53.Suppl_2.12.4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaad.2013.06.027","article-title":"Topical treatments for chronic plaque psoriasis: an abridged Cochrane systematic review","volume":"69","author":"Mason","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2026090108200770000_53.Suppl_2.12.5","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00655-y"},{"key":"2026090108200770000_53.Suppl_2.12.6","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/235680"},{"key":"2026090108200770000_53.Suppl_2.12.7","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12276"},{"key":"2026090108200770000_53.Suppl_2.12.8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1468-3083.2012.04522.x","article-title":"Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities","volume":"26","author":"Castela","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026090108200770000_53.Suppl_2.12.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04524.x"},{"key":"2026090108200770000_53.Suppl_2.12.10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/12034754020060S303","article-title":"Topical agents for the treatment of psoriasis, past, present and future","volume":"6","author":"Tremblay","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"2026090108200770000_53.Suppl_2.12.11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/09546634.2019.1675855","article-title":"Psoriasis patient preferences for topical drugs: a systematic review","volume":"32","author":"Svendsen","year":"2021","journal-title":"J Dermatol Treat"},{"key":"2026090108200770000_53.Suppl_2.12.12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/bjd.12393","article-title":"Topical treatments for chronic plaque psoriasis of the scalp: a systematic review","volume":"169","author":"Mason","year":"2013","journal-title":"Br J Dermatol"},{"key":"2026090108200770000_53.Suppl_2.12.13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1468-3083.2009.03358.x","article-title":"Topical corticosteroids in psoriasis: strategies for improving safety","volume":"24","author":"Horn","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026090108200770000_53.Suppl_2.12.14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.12788\/cutis.0573","article-title":"Management of psoriasis with topicals: applying the 2020 AAD-NPF guidelines of care to clinical practice","volume":"110","author":"Chat","year":"2022","journal-title":"Cutis"},{"key":"2026090108200770000_53.Suppl_2.12.15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.annder.2019.03.005","article-title":"[French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults]","volume":"146","author":"Amatore","year":"2019","journal-title":"Ann Dermatol Venereol"},{"key":"2026090108200770000_53.Suppl_2.12.16","doi-asserted-by":"crossref","first-page":"2200570","DOI":"10.1080\/09546634.2023.2200570","article-title":"Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectiveness","volume":"34","author":"Ninosu","year":"2023","journal-title":"J Dermatol Treat"},{"key":"2026090108200770000_53.Suppl_2.12.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103629"},{"key":"2026090108200770000_53.Suppl_2.12.18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2022.15632","article-title":"Effect of Roflumilast cream vs vehicle cream on chronic plaque psoriasis: the DERMIS-1 and DERMIS-2 randomized clinical trials","volume":"328","author":"Lebwohl","year":"2022","journal-title":"JAMA"},{"key":"2026090108200770000_53.Suppl_2.12.19","unstructured":"Elder AJ , Patel P , Daveluy S , ed. Tapinarof. [Updated 2023 Aug 6]. Treasure Island: StatPearls Publishing; 2026. [Internet. Accessed April 29, 2026.] Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK594244\/"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2026-0440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:20:15Z","timestamp":1788276015000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2026-0440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":19,"journal-issue":{"issue":"Suppl 2","published-online":{"date-parts":[[2026,9,1]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.3899\/jrheum.2026-0440"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2026-0440","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}